发明授权
EP2809657B1 NOVEL THERAPEUTIC AGENTS 有权
新型治疗剂

NOVEL THERAPEUTIC AGENTS
摘要:
The present invention relates to a class of hydroxamic acid compounds of Formula (I), which act as alkylating agents and/or inhibitors of the HDAC pathway, having potential utility in the treatment of a neoplastic disease and immune diseases.
公开/授权文献
信息查询
0/0